Non‐invasive, quantitative assessment of the anatomical phenotype of corticotropin‐releasing factor‐overexpressing mice by MRI
- 11 May 2001
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 14 (3) , 210-216
- https://doi.org/10.1002/nbm.704
Abstract
High resolution magnetic resonance imaging (MRI) was applied to quantify alterations in thymus and adrenal volumes, as well as body fat in genetically engineered corticotropin‐releasing factor (CRF)‐overexpressing mice. When compared to the organs in age‐matched wild‐type animals, the adrenals in CRF‐overexpressing male mice were significantly enlarged and the thymus volume in females was significantly smaller. The fat content was significantly larger in CRF‐overexpressing mice. The anatomical alterations observed in the MRI studies were in perfect line with post‐mortem data (weights of organs). Furthermore, the observed interstrain differences are in agreement with recently published data on (i) the effect of continuous, intraventricular infusion of CRF in rats and (ii) the presence of atrophic adrenals in CRF‐knockout mice. The present studies demonstrate that MRI can provide reliable measures of relatively small structures such as the adrenal glands and the thymus in mice. This makes MRI an attractive, non‐terminal tool to monitor in laboratory animals, including transgenic mice, the consequence of continuous stress on relevant organs. Copyright © 2001 John Wiley & Sons, Ltd. Abbreviations used:: ACTH adrenocorticotropin CRF corticotropin‐releasing factor CT computed tomography FOV field‐of‐view HPA hypothalamic–pituitary–adrenal i.d. internal diameter PCR polymerase chain reaction tg transgenic TE echo time TR repetition time wt wild‐typeKeywords
This publication has 21 references indexed in Scilit:
- From anatomy to the target: Contributions of magnetic resonance imaging to preclinical pharmaceutical researchThe Anatomical Record, 2001
- Adrenal imagingBJU International, 2000
- Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treatedJournal of Psychiatric Research, 2000
- Animal Models of CRH DeficiencyFrontiers in Neuroendocrinology, 1999
- Understanding corticotropin releasing factor neurobiology: contributions from mutant miceNeuropeptides, 1999
- CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.Proceedings of the National Academy of Sciences, 1996
- Comparison of Adrenocortical Zonation in C57BL/6J and DDD Mice.Experimental Animals, 1995
- Behavioral and cardiac responses after intracerebroventricular corticotropin-releasing hormone (CRH) administration: Role of adrenal cortical hormonesHormones and Behavior, 1992
- Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice.Endocrinology, 1992